Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections

International Journal of Antimicrobial Agents

Volumn 42, Issue 6, 2013, Pages 497-499

  Cunha, Burke A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

CA MRSA; Doxycycline; Empirical treatment; Minocycline; Trimethoprim sulfamethoxazole; Uncomplicated skin and soft tissue infection

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LINEZOLID; MINOCYCLINE;

ABSCESS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; CLINICAL EFFECTIVENESS; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; DRUG PREFERENCE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENDOCARDITIS; GASTROINTESTINAL SYMPTOM; HOSPITAL INFECTION; HUMAN; HYPERPIGMENTATION; INFLUENZA; LUPUS VULGARIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION;

CA-MRSA; DOXYCYCLINE; EMPIRICAL TREATMENT; MINOCYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE; UNCOMPLICATED SKIN AND SOFT-TISSUE INFECTION;

ABSCESS; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINOCYCLINE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84889085028     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.08.006     Document Type: Note

References (19)

1. B.A. Cunha Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy Clin Microbiol Infect 11 Suppl. 4 2005 33 42
2. B.A. Cunha Oral antibiotic treatment of MRSA infections J Hosp Infect 60 2005 88 90 Erratum in: J Hosp Infect 2006;62:130
3. B.A. Cunha Cephalexin remains preferred oral antibiotic therapy for uncomplicated cellulitis Am J Med 121 2008 e13
4. D.J. Pallin, W.D. Binder, M.B. Allen, M. Lederman, S. Parmar, and M. Filbin Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial Clin Infect Dis 56 2013 1754 1762
5. B.A. Cunha Problems arising in antimicrobial therapy due to false susceptibility testing J Chemother 9 Suppl. 1 1997 25 35
6. B.A. Cunha Oral antibiotic therapy of serious systemic infections Med Clin North Am 90 2006 1197 1222
7. B.A. Cunha Antibiotic essentials 12th ed. 2013 Jones & Bartlett Sudbury, MA 1 16 132-42
8. B.A. Cunha Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness Int J Antimicrob Agents 35 2010 517 518
9. B.S. Schwartz, C.J. Graber, B.A. Diep, L. Basuino, F. Perdreau-Remington, and H.F. Chambers Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300 Clin Infect Dis 48 2009 1483 1484
10. A. Kucers, S.M. Crowe, M.L. Grayson, and J.F. Hoy Kucers' the use of antibiotics 5th ed. 1997 Butterworth Heinemann Oxford, UK 719 763
11. M.J. Cenizal, D. Skiest, S. Luber, R. Bedimo, P. Davis, and P. Fox Prospective randomized trial of empiric therapy with trimethoprim- sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 51 2007 2628 2630
12. G. De Angelis, M. Cipriani, R. Cauda, and E. Tacconelli Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole Clin Infect Dis 52 2011 1471 1472
13. S.A. Grim, R.P. Rapp, C.A. Martin, and M.E. Evans Trimethoprim- sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus Pharmacotherapy 25 2005 453 464
14. G.J. Moran, A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, and R.B. Carey Methicillin-resistant S. aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
15. R.A. Proctor Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 2008 584 593
16. A. Párez, L. Orta, M. Pascual, E. Padilla, X. Mesquida, and M. González Management of mild CA-MRSA skin infections: more complicated than it looks at a glance Eur J Dermatol 22 2012 800 801
17. J.D. Szumowski, D.E. Cohen, F. Kanaya, and K.H. Mayer Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic Antimicrob Agents Chemother 51 2007 423 428
18. G. Pappas, A.P. Athanasoulia, D.K. Matthaiou, and M.E. Falagas Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative? J Chemother 21 2009 115 126
19. J.B. Wood, D.B. Smith, E.H. Baker, S.M. Brecher, and K. Gupta Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis Antimicrob Agents Chemother 56 2012 5655 5660